RSV vaccine could help protect some adults as young as 50, drugmaker says
By Amanda Musa, CNN (CNN) — An RSV vaccine approved for use in older adults could help protect people as young as 50 who have certain underlying medical conditions and are at increased risk from the respiratory virus, according to preliminary data released by vaccine maker GSK. The company said it would submit the information to the
Continue Reading